Sitemap

November 08, 2019 Articles

Filter by Available Specialty
  1. ACAAI Scientific Meeting to highlight clinical updates
  2. ACG meeting highlights make up top stories in gastroenterology
  3. Acquired factors lead to arteriovenous fistula clotting in patients on dialysis
  4. AKI with major complications linked to decreased survival following coronary artery bypass grafting
  5. Albumin, liver stiffness after DAA therapy for HCV stratify liver cancer risk
  6. Andrea M. Russo, MD, emphasizes importance of learning, collaboration
  7. Anti-CD73 antibody agent appears safe, shows promise in advanced cancers
  8. ATTEST
  9. BLOG: Hemianopia or spatial neglect – can you tell the difference?
  10. BLOG: Observations regarding the trochlea morphology in trochlea dysplasia
  11. CDC: Vitamin E acetate, THC implicated in vaping-related lung injury outbreak
  12. Cedars-Sinai receives $10.5 million to study RP stem cell treatment
  13. Conformis receives FDA clearance for next-generation hip system
  14. Consider hypoglycemia risks when helping adults with diabetes lose weight
  15. Consider patient adherence when prescribing allergy immunotherapy
  16. Creatine equations comparable to measured GFR for HIV-positive patients
  17. Crisis pregnancy centers pose risk to adolescent health, experts say
  18. CV controversy of ADHD medication use in children and adolescents
  19. 'Destination care' lowers costs, improves satisfaction in bariatric surgery
  20. EARNEST-PVI
  21. Electrophysiology training in crisis
  22. Elevated infection risk remains following treatment for obesity
  23. Entyvio exhibits favorable real-world safety profile in biologic-naive IBD patients
  24. Experts discuss implementing food allergy therapy into practice
  25. Experts optimize the total-body skin exam
  26. FDA accepts new drug application for acne cream
  27. FDA approves Reblozyl for beta-thalassemia
  28. FDA may withdraw approval of drug that manufacturer says prevents preterm birth
  29. GALACTIC
  30. Gluten-free diet unlikely to prevent psoriatic diseases, atopic dermatitis
  31. HBV update: 5 reports on best practices toward elimination
  32. HELP-AF
  33. HF pharmacotherapy in midst of paradigm shift
  34. IDEAL-LM
  35. In explaining rise of obesity, diabetes, look toward unanswered questions
  36. Lithium reduction during pregnancy and postpartum period lowers fetal health risks
  37. Look AHEAD
  38. Mental health not impacted by long-term social media use
  39. Mortality risk increases after elective noncardiac surgery in women with HF
  40. MRI-, CT-based 3D models had similar diagnostic values for femoroacetabular impingement
  41. Neighborhood walkability correlates to CVD risk, smoking prevalence
  42. New trials elevate focus on polypill strategy for CVD prevention
  43. Nortriptyline ‘good candidate’ for frontline neuropathic corneal pain treatment
  44. OCTANe expands reach with creation of new signature meeting
  45. Ocuphire advances Nyxol to address varied ocular indications
  46. Omidria lessens need for fentanyl during cataract surgery
  47. Oncology Care Model: Progress along the learning curve
  48. PARP inhibitors take big step toward changing practice
  49. Predictors of response to Stelara identified in Crohn’s
  50. Q&A: High-intensity vs. low-intensity prospective audit and feedback
  51. SCOPE I
  52. Study: ANG-3777 improves renal function in transplant recipients with delayed graft function
  53. Surgeon receives Association of Community Cancer Centers’ clinical scientist award
  54. Symptom burden a key component of disease control assessment in polycythemia vera
  55. Top pulmonology news from October: ERS International Congress coverage, effects of e-cigarettes and more
  56. TWILIGHT
  57. VIDEO: Complete depletion of peripheral B cells with obinutuzumab in lupus nephritis
  58. VIDEO: Eyevance co-founder highlights recent activities
  59. VIDEO: Why aren't hospitals using new antibiotics?
  60. VITAL: Vitamin D, omega-3 do not preserve kidney function in type 2 diabetes
  61. Weight loss recommended to decrease CV risk in metabolically healthy obesity
  62. Will the use of PARP inhibitors in advanced ovarian cancer with wild-type BRCA lead to improved OS rates?